Cargando…

Audit feedback interventions to address high-risk prescriptions in long-term care homes: a costing study and return on investment analysis

BACKGROUND: Audit and feedback is a common implementation strategy, but few studies describe its costs. ‘MyPractice’ is a province-wide audit and feedback initiative to improve prescribing in nursing homes. This study sought to estimate the costs of ‘MyPractice’ and assess whether the financial bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Thavorn, Kednapa, Kumar, Srishti, Reis, Catherine, Lam, Jonathan, Dobell, Gail, Mulhall, Cara, Grimshaw, Jeremy M., Ivers, Noah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554856/
https://www.ncbi.nlm.nih.gov/pubmed/34711294
http://dx.doi.org/10.1186/s43058-021-00225-7
_version_ 1784591875741581312
author Thavorn, Kednapa
Kumar, Srishti
Reis, Catherine
Lam, Jonathan
Dobell, Gail
Mulhall, Cara
Grimshaw, Jeremy M.
Ivers, Noah
author_facet Thavorn, Kednapa
Kumar, Srishti
Reis, Catherine
Lam, Jonathan
Dobell, Gail
Mulhall, Cara
Grimshaw, Jeremy M.
Ivers, Noah
author_sort Thavorn, Kednapa
collection PubMed
description BACKGROUND: Audit and feedback is a common implementation strategy, but few studies describe its costs. ‘MyPractice’ is a province-wide audit and feedback initiative to improve prescribing in nursing homes. This study sought to estimate the costs of ‘MyPractice’ and assess whether the financial benefit of ‘MyPractice’ offsets those costs. METHODS: We conducted a costing study from the perspective of the Ontario government. Total cost of ‘MyPractice’ was calculated as the sum of the costs of producing and disseminating the reports (covering three report releases) which were obtained from Ontario Health staff interviews and document reviews. Return on investment (ROI) was calculated as the ratio of net cost-savings and the intervention cost. Cost savings were based on the effectiveness of ‘MyPractice’ derived from a published cohort study. Cost-savings attributable to ‘MyPractice’ were estimated from the changes in the rates of antipsychotics over time between physicians who signed up and viewed the reports and those who did not sign up to the reports. RESULTS: Total intervention costs were C$223,691 (C$838 per physician and C$74,564 per release). Costs incurred during the development phase accounted for 74% of the total cost (C$166,117), while implementation costs for three report releases were responsible for 26% of the total costs (C$57,575). The ROI for every C$1 spent on the ‘MyPractice’ intervention was 1.02 (95% CI 0.51, 1.93) for three report releases. CONCLUSION: ‘MyPractice’ report offers a good return on investment and the value for money could improve with greater number of report releases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43058-021-00225-7.
format Online
Article
Text
id pubmed-8554856
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85548562021-11-01 Audit feedback interventions to address high-risk prescriptions in long-term care homes: a costing study and return on investment analysis Thavorn, Kednapa Kumar, Srishti Reis, Catherine Lam, Jonathan Dobell, Gail Mulhall, Cara Grimshaw, Jeremy M. Ivers, Noah Implement Sci Commun Short Report BACKGROUND: Audit and feedback is a common implementation strategy, but few studies describe its costs. ‘MyPractice’ is a province-wide audit and feedback initiative to improve prescribing in nursing homes. This study sought to estimate the costs of ‘MyPractice’ and assess whether the financial benefit of ‘MyPractice’ offsets those costs. METHODS: We conducted a costing study from the perspective of the Ontario government. Total cost of ‘MyPractice’ was calculated as the sum of the costs of producing and disseminating the reports (covering three report releases) which were obtained from Ontario Health staff interviews and document reviews. Return on investment (ROI) was calculated as the ratio of net cost-savings and the intervention cost. Cost savings were based on the effectiveness of ‘MyPractice’ derived from a published cohort study. Cost-savings attributable to ‘MyPractice’ were estimated from the changes in the rates of antipsychotics over time between physicians who signed up and viewed the reports and those who did not sign up to the reports. RESULTS: Total intervention costs were C$223,691 (C$838 per physician and C$74,564 per release). Costs incurred during the development phase accounted for 74% of the total cost (C$166,117), while implementation costs for three report releases were responsible for 26% of the total costs (C$57,575). The ROI for every C$1 spent on the ‘MyPractice’ intervention was 1.02 (95% CI 0.51, 1.93) for three report releases. CONCLUSION: ‘MyPractice’ report offers a good return on investment and the value for money could improve with greater number of report releases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43058-021-00225-7. BioMed Central 2021-10-28 /pmc/articles/PMC8554856/ /pubmed/34711294 http://dx.doi.org/10.1186/s43058-021-00225-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Report
Thavorn, Kednapa
Kumar, Srishti
Reis, Catherine
Lam, Jonathan
Dobell, Gail
Mulhall, Cara
Grimshaw, Jeremy M.
Ivers, Noah
Audit feedback interventions to address high-risk prescriptions in long-term care homes: a costing study and return on investment analysis
title Audit feedback interventions to address high-risk prescriptions in long-term care homes: a costing study and return on investment analysis
title_full Audit feedback interventions to address high-risk prescriptions in long-term care homes: a costing study and return on investment analysis
title_fullStr Audit feedback interventions to address high-risk prescriptions in long-term care homes: a costing study and return on investment analysis
title_full_unstemmed Audit feedback interventions to address high-risk prescriptions in long-term care homes: a costing study and return on investment analysis
title_short Audit feedback interventions to address high-risk prescriptions in long-term care homes: a costing study and return on investment analysis
title_sort audit feedback interventions to address high-risk prescriptions in long-term care homes: a costing study and return on investment analysis
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554856/
https://www.ncbi.nlm.nih.gov/pubmed/34711294
http://dx.doi.org/10.1186/s43058-021-00225-7
work_keys_str_mv AT thavornkednapa auditfeedbackinterventionstoaddresshighriskprescriptionsinlongtermcarehomesacostingstudyandreturnoninvestmentanalysis
AT kumarsrishti auditfeedbackinterventionstoaddresshighriskprescriptionsinlongtermcarehomesacostingstudyandreturnoninvestmentanalysis
AT reiscatherine auditfeedbackinterventionstoaddresshighriskprescriptionsinlongtermcarehomesacostingstudyandreturnoninvestmentanalysis
AT lamjonathan auditfeedbackinterventionstoaddresshighriskprescriptionsinlongtermcarehomesacostingstudyandreturnoninvestmentanalysis
AT dobellgail auditfeedbackinterventionstoaddresshighriskprescriptionsinlongtermcarehomesacostingstudyandreturnoninvestmentanalysis
AT mulhallcara auditfeedbackinterventionstoaddresshighriskprescriptionsinlongtermcarehomesacostingstudyandreturnoninvestmentanalysis
AT grimshawjeremym auditfeedbackinterventionstoaddresshighriskprescriptionsinlongtermcarehomesacostingstudyandreturnoninvestmentanalysis
AT iversnoah auditfeedbackinterventionstoaddresshighriskprescriptionsinlongtermcarehomesacostingstudyandreturnoninvestmentanalysis